Literature DB >> 8610509

Effects of iodinated contrast media on peripheral blood flow.

N D Pugh1, T M Griffith, J O Karlsson.   

Abstract

All types of clinically employed iodinated roentgen contrast media (CM) cause vasodilatation after i.a. and i.v. administration, regardless of precise molecular structure. It is now apparent, however, that at iodine concentrations which provide equivalent angiographic contrast, this is significantly less with newer hexa-iodinated dimers, such as iodixanol and iotrolan, than older generations of compounds. The cellular mechanisms that underly the vasodilator effects of CM still remain to be fully elucidated but may include a) effects attributable to hyperosmolality; b) stimulation of the release of endogenous vasoactive mediators; and c) direct relaxant effects upon vascular smooth muscle. This review will discuss the possible contributions of these mechanisms to the vasodilatation observed in the clinical situation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8610509     DOI: 10.1177/0284185195036s39918

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  3 in total

1.  Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta.

Authors:  M R Pitman; J O Karlsson; T M Griffith
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  High Concentration of Iopromide Induces Apoptosis and Autophagy in Human Embryonic Kidney Cells via Activating a ROS-dependent Cellular Stress Pathway.

Authors:  Yuh-Feng Tsai; Jai-Sing Yang; Fuu-Jen Tsai; Yih-Dih Cheng; Yu-Jen Chiu; Shih-Chang Tsai
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM).

Authors:  Jai-Sing Yang; Yan-Ru Peng; Shih-Chang Tsai; Yeu-Sheng Tyan; Chi-Cheng Lu; Hong-Yi Chiu; Yu-Jen Chiu; Sheng-Chu Kuo; Yuh-Feng Tsai; Ping-Chin Lin; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2018-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.